Nicholas Investment Partners, LP Opti Nose, Inc. Transaction History

Nicholas Investment Partners, LP

  • $912 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.84 - $11.92 $1.78 Million - $3.62 Million
-304,032 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$12.43 - $29.76 $47,631 - $114,040
-3,832 Reduced 1.24%
304,032 $3.78 Million
Q2 2018

Aug 14, 2018
BUY
$18.75 - $28.46 $5.77 Million - $8.76 Million
307,864 New
307,864 $8.61 Million

Others Institutions Holding OPTN

# of Institutions
2
Shares Held
5.29M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $496M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email